The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Roche Canada
Research Funding - LabCorp; Pfizer
Biomarker data from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer.
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Amgen; Daiichi Sankyo; MSD Oncology
Patents, Royalties, Other Intellectual Property - Patent application EP20150702464 -therapy response; Patent application: EP18209672 -cancer immunotherapy; VMScope digital pathology software
 
Chiara Lambertini
Employment - Roche
 
Peter A. Fasching
Honoraria - Amgen; AstraZeneca; BioNTech (Inst); Celgene; Cepheid (Inst); Daiichi Sankyo; Eisai; Hexal; Lilly; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Macrogenics; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Research Funding - BioNTech (Inst); Cepheid (Inst); Novartis (Inst)
 
Katherine L. Pogue-Geile
Research Funding - NSABP Foundation (Inst)
Patents, Royalties, Other Intellectual Property - The following patent was submitted: U. S. Patent Application Serial No. 14/738,757, entitled: “Methods of Subtyping CRC and their Association with Treatment of Colon Cancer Patients with Oxaliplatin." Published 12/24/15.
 
Max S. Mano
Stock and Other Ownership Interests - Fleury Group; Grupo Biotoscana; Hypera Pharma
Honoraria - Lilly/ImClone; Novartis; Oncologia Brasil; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Lilly/ImClone; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
(OPTIONAL) Uncompensated Relationships - Roche
 
Michael Untch
Honoraria - Art tempi (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); MSD Oncology (Inst); Mundipharma (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche Pharma AG (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Celgene (Inst); Lilly (Inst); MSD Oncology (Inst); Mundipharma (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
 
Norman Wolmark
No Relationships to Disclose
 
Chiung-Sheng Huang
Honoraria - Amgen; AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Pfizer; Roche
Speakers' Bureau - Amgen; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche
 
Sibylle Loibl
Honoraria - Chugai Pharma
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Cepheid (Inst); Daiichi Sankyo (Inst); Immunomedics (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Vifor Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)
 
Eleftherios P. Mamounas
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo; Genomic Health; Merck; Roche/Genentech
Speakers' Bureau - Genentech/Roche; Genomic Health
Travel, Accommodations, Expenses - Genentech/Roche; Genomic Health
 
Gunter Von Minckwitz
Stock and Other Ownership Interests - CARA GmbH
 
Charles E. Geyer
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Daiichi Sankyo; Genentech/Roche
 
Thomas Boulet
Employment - Roche/Genentech
 
Chunyan Song
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Gail Lewis Phillips
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Malgorzata Nowicka
Employment - Roche
 
Sanne de Haas
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Mark Basik
No Relationships to Disclose